Consortium advancing care and prevention of cancers in people with HIV
Official title: Consortium for Advancing Management and Prevention of Cancer in People with HIV
Funded at Icahn School of Medicine at Mount Sinai · NIH-11535258 · Data updated 2026-11-12
A national and international network is testing new cancer treatments and prevention strategies for people living with HIV to help reduce cancer-related illness and death.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | August 29, 2006 |
| Project end | August 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $276,428 |
| NIH project number | 3UM1CA121947-20SA |
| Project ID | NIH-11535258 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults living with HIV who are at risk for or diagnosed with AIDS-related cancers and who are eligible for participating clinical trials at AMC sites.
✕Less likely to help
Patients not eligible for specific trials or those whose cancer type is not targeted by AMC interventions may not benefit directly.
What this research studies
The AIDS Malignancy Consortium coordinates clinical trials to test new ways to treat and prevent cancers that occur more often in people with HIV. It works with a network of trial sites around the U.S. and in other countries to study how cancers in PLWH respond to modern therapies and supportive care. The program also focuses on understanding the biology of these cancers and translating findings into practice guidelines to improve patient outcomes. Participants may contribute by enrolling in trials or through involvement in community advisory activities and translational research opportunities. The initiative has a long history of engaging PLWH and survivors to shape research priorities and share findings with the community.
Why it matters
Potential benefit: If successful, the program could lead to better cancer prevention, earlier detection, and more effective treatments for people living with HIV.
How similar studies have gone: AMC has conducted numerous interventional trials and has influenced guidelines, showing prior success in improving care for PLWH with cancer.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Sparano, Joseph a. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Sparano, Joseph a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.